Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 93, Issue 4, 2002, Pages 440-445

  Amador, Armando G ^a,b   Righi, Paul D ^c   Radpour, Shokri ^d   Everett, Eric T ^a,c   Weisberger, Edward ^c   Langer, Mark ^c   Eckert, George J ^c   Christen, Arden G ^b   Campbell Jr , Samuel ^b   Summerlin, Don Jon ^b   Reynolds, Nichole ^b   Hartsfield Jr , James K ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; EPOXIDE HYDROLASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GSTP1 PROTEIN, HUMAN; HISTIDINE; ISOENZYME; TYROSINE;

ADULT; AGED; ALLELE; ARTICLE; CARCINOMA; CODON; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HOMOZYGOTE; HUMAN; MALE; MIDDLE AGED; OROPHARYNX TUMOR; SEX DIFFERENCE; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASPARTIC ACID; CARCINOMA; CODON; EPOXIDE HYDROLASES; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HISTIDINE; HOMOZYGOTE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; SEX FACTORS; STATISTICS; TYROSINE;

EID: 19044397568     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2002.122586     Document Type: Article

References (16)

1. Rojas M, Cascorbi I, Alexandrov K, Kriek E, Auburtin G, Mayer L, et al. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis 2000;21:35-41.
2. Sato M, Sato T, Izumo T, Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999;20:1927-31.
3. Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H. Glutathione s-transferase genotypes as risk factors for head and neck cancer. Am J Surg 1995;170:499-501.
4. Nair UJ, Nair J, Mathew B, Bartsch H. Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 1999;20:743-8.
5. Park JY, Muscat JE, Ren Q, Schantz SP, Harwick RD, Stern JC, et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6:791-7.
6. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994;3:421-8.
7. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996;6:187-91.
8. Nedelcheva Kristensen V, Andersen TI, Erikstein B, Geitvik G, Skovlund E, Nesland JM, et al. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics 1998;8:441-7.
9. Agresti A. Categorical data analysis. New York: John Wiley & Sons: 1990.
10. SAS/STAT® User's Guide, Version 6, Fourth Edition, Volume 2, Cary (NC): SAS Institute Inc; 1998.
11. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 2000;60:534-6.
12. Kessler R, Hamou MF, Albertoni M, de Tribolet N, Arand M, Van Meir EG. Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase. Cancer Res 2000;60:1403-9.
13. McNees AG, O'Donnell M, Horton PH, Kim HY, Kim SJ, Hams CM, et al. Lack of correlation between in vitro and in vivo replication of precisely defined benz-a-anthracene adducted DNAs. J Biol Chem 1997;272:33211-9.
14. Yuen J, Ekbom A, Trichopoulos D, Hsieh CC, Adami HO. Season of birth and breast cancer risk in Sweden. Br J Cancer 1994;70:564-8.
15. Amador AG, Eckert G, Larby K, Hartsfield, JK Jr. Seasonality of birth in patients with various types of reproductive tract or head and neck neoplasias. Transac Ill St Acad Sci 2000;93 Suppl:74.
16. Kristoffersen S, Harveit F. Is a woman's date of birth related to her risk of developing breast cancer? Oncol Rep 2000;7:245-247.